UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
Abstract Background: A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs)…
Mikael H Sodergren
Awareness of medical cannabis regulations among UK police officers – a cross-sectional study
Abstract Cannabis-based products for medicinal use were rescheduled in the UK in November 2018. The primary outcomes of this cross-sectional…
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Abstract Introduction: The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for…
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Abstract Rationale: Cannabis-based medicinal products (CBMPs) have been identified as novel therapeutics for generalised anxiety disorder (GAD) based on pre-clinical…
Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom
Abstract Background: In the UK, legislation and regulations governing medical cannabis and over the counter cannabidiol (CBD) wellness products have…
Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons
Abstract Background: The analgesic effects of Cannabis sativa are mediated by ∆9 tetrahydrocannabinol (THC), but the contributions of other bioactive…